From : Averhoff, Francisco (CDC/OID/NCHHSTP) <fma0@cdc.gov>
To : David Sergeenko; Gregg Alton; Valeri Kvaratskhelia; Ward; John; Diana Brainard; valeri
Subject : RE: Georgia Oversight Committee: 2nd Meeting Proposed for 25 August?
Cc : Nasrullah; Muazzam; Morgan; Juliette; Gamkrelidze; Amiran; Christina Carlson; Glass; Nancy; Skaggs; Beth; Graeme Robertson; Ruth Diazaraque-Marin; Betty Chiang; Lia Gvinjilia
Received On : 17.08.2016 18:06

Dear all,

 

It appears that due to conflicts, some key members will not be available this date, so we will plan to reschedule for another date.

 

Also, I would like to offer for consideration in-person OC meeting on 23 October, the evening before the TAG meeting in Tbilisi, 24-25 October, as I think most will be in attendance for the meeting.

 

Look for a f/u date proposal for our next call.

 

Thank you, FA

 

Francisco Averhoff MD, MPH

CAPT US Public Health Service

Associate Director for Global Health

Division of Viral Hepatitis

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Centers for Disease Control and Prevention

1600 Clifton Road, MS G-37

Atlanta, GA 30333

phone: 404-718-8501

fax: 404-718-8588

e-mail: fma0@cdc.gov

 

 

From: Averhoff, Francisco (CDC/OID/NCHHSTP)
Sent: Wednesday, August 10, 2016 4:22 PM
To: Davit Sergeenko (dsergeenko@moh.gov.ge) ; Gregg Alton ; Valeri Kvaratskhelia ; Ward, John (CDC/OID/NCHHSTP) ; 'Diana Brainard' ; valeri
Cc: Nasrullah, Muazzam (CDC/OID/NCHHSTP) ; Morgan, Juliette (CDC/CGH/DGHP) ; Amiran Gamkrelidze (a.gamkrelidze@ncdc.ge) ; Christina Carlson ; Glass, Nancy (CDC/OID/NCHHSTP) (CTR) ; Skaggs, Beth (CDC/CGH/DGHP) ; Graeme Robertson (Graeme.Robertson@gilead.com) ; Ruth Diazaraque-Marin
Subject: Georgia Oversight Committee: 2nd Meeting Proposed for 25 August?

 

Dear Oversight Committee Members,

 

I would like to thank GS for the attached minutes of the last OC call, which accurately reflected the discussions.  I would also like to propose the next OC meeting for late August, as Muazzam and I from DVH will be in Tbilisi during this time; we thought it would be good if we could schedule a meeting for  25 August.   Please advise if this is agreeable, to OC members.  Let us know if this date works, we can collectively develop agenda as we approach the date.  I have added CDC potential observers to this communication.

 

Best regards, FA

 

Francisco Averhoff MD, MPH

CAPT US Public Health Service

Associate Director for Global Health

Division of Viral Hepatitis

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Centers for Disease Control and Prevention

1600 Clifton Road, MS G-37

Atlanta, GA 30333

phone: 404-718-8501

fax: 404-718-8588

e-mail: fma0@cdc.gov

 

 

From: Christina Carlson [mailto:Christina.Carlson@gilead.com]
Sent: Tuesday, July 19, 2016 3:43 PM
To: Gregg Alton <Gregg.Alton@gilead.com>; Averhoff, Francisco (CDC/OID/NCHHSTP) <fma0@cdc.gov>; Graeme Robertson <Graeme.Robertson@gilead.com>
Cc: Diana Brainard <Diana.Brainard@gilead.com>; Ruth Diazaraque-Marin <Ruth.Diazaraque-Marin@gilead.com>; Ward, John (CDC/OID/NCHHSTP) <jww4@cdc.gov>; Davit Sergeenko <dsergeenko@moh.gov.ge>; Valeri (Georgia) <v.kvaratskhelia@outlook.com>; valeri <vkvaratskhelia@moh.gov.ge>
Subject: RE: Oversight Committee Call/Agenda [GILEAD-GEN-LEGAL.FID44578]

 

All – please see attached meeting minutes from the Oversight committee call that took place on June 30.  Please let me know if there are any comments.

 

Kind Regards,

Christina

 

From: Gregg Alton
Sent: Wednesday, June 22, 2016 4:54 PM
To: Averhoff, Francisco (CDC/OID/NCHHSTP); Graeme Robertson
Cc: Diana Brainard; Ruth Diazaraque-Marin; Christina Carlson; Ward, John (CDC/OID/NCHHSTP); Davit Sergeenko; Valeri (Georgia); valeri
Subject: Oversight Committee Call/Agenda

 

Attached please find a draft agenda for the oversight committee meeting schedule for June 30. Please review and let me know if you have any changes, additions or questions.

 

I look forward to the meeting.

 

Thank you,

Gregg

 

Gregg Alton

Executive Vice President, Commercial and Access Operations ALA, Corporate and Medical Affairs

Gilead Sciences, Inc.

333 Lakeside Drive, Foster City, CA 94404

(650) 522-5783 (phone)

(650) 522-5537 (private fax)

galton@gilead.com

 This email message is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply email and destroy all copies of the original message.